by Maria Zannes | May 15, 2023 | Press Releases
SAN ANTONIO, Texas (May 15, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for the three...
by Maria Zannes | May 8, 2023 | Articles, News
bioAffinity Technologies CEO Maria Zannes says the company has made a key hire May 4, 2023 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San Antonio Business Journal BioAffinity Technologies Inc. has made a key change in its...
by Maria Zannes | May 1, 2023 | Press Releases
SAN ANTONIO, Texas (May 1, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer, today announced that Michael Dougherty has joined the company...
by Maria Zannes | Apr 25, 2023 | Press Releases
SAN ANTONIO, Texas (April 25, 2023) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer, will present at the Cleveland Clinic’s invitation-only...
by Maria Zannes | Apr 18, 2023 | Events
APRIL 18, 2023 bioAffinity Technologies President and CEO Maria Zannes will address the Austin/San Antonio chapter of the Association for Corporate Growth (ACG) at a luncheon event on Tuesday, April 25, 2023. ACG is a global community for middle-market dealmakers and...
